Pre-formulation Research

Create: 03/26/2019

Expired Date:	never
Category:	Drugs&Pharmaceutical [Health&Medical&Pharmaceutical]
Message:	Creative Biolabs can provide pre-formulation research through our CreDA™ developability assessment platform to address formulation for the drug candidate selection. Therapy biologics, especially monoclonal antibodies, often require single doses of several mg/kg, with intravenous injection or infusion being the preferred administration routes. Most diseases, which are treated with antibody-based pharmaceuticals, are chronic and require continuous therapy. With regard to patient convenience and healthcare costs, it would be of great benefit if these drugs could be self-administered through subcutaneous/intramuscular injection by the patient. https://www.creative-biolabs.com/pre-formulation-research.html






City:	Shirley[US]
Location:

Feb 01 2023	VBS⁺⁺ (with Ca and Mg) Buffer	233
Feb 01 2023	GVBE Buffer	234
Feb 01 2023	GVB⁺⁺ (with Ca and Mg) Buffer	240
Feb 01 2023	Hemolysin (Rabbit Anti-Sheep Cell Hemolysin)	228
Aug 30 2019	Anti-HSV-2 gH Antibody	421
Aug 30 2019	Anti-L. major LPG Antibody	503
Aug 30 2019	Anti-DENV-1 Antibody	413
Aug 30 2019	Anti-BPV-1 L1 Antibody	429
Aug 30 2019	Anti-H3N2 HA Antibody	410
Aug 30 2019	Anti-EIAV env Antibody	438